Case Report

Biliary Fascioliasis Mimicking Sphincter of Oddi Dysfunction

Authors: Jonathan Keshishian, MD, Stephen G. Brantley, MD, Patrick G. Brady, MD


Fasciola hepatica, a liver fluke of livestock, rarely presents as chronic biliary tract infection in humans. We report a 38-year-old woman from Ethiopia who presented with right upper quadrant pain and a dilated common bile duct on ultrasound and magnetic resonance cholangiopancreatography (MRCP) without other abnormalities. She was suspected to have type II sphincter of Oddi dysfunction. She underwent endoscopic retrograde cholangiopancreatography (ERCP) and had a fluke, diagnosed as Fasciola hepatica, in the common hepatic duct. This report confirms the diagnostic and therapeutic role of ERCP in the management of biliary fascioliasis, and highlights the need to include fascioliasis in the differential diagnosis of biliary pain in patients emigrating from areas where this infection is endemic.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.


1. Lim JH, Mairiang E, Ahn GH. Biliary parasitic diseases including clonorchiasis, opisthorchiasis and fascioliasis. Abdom Imaging 2008;33:157–165.
2. Hasseb AN, el-Shazly AM, Arafa MA, et al. A review on fascioliasis in Egypt. J Egypt Soc Parasitol 2002;32:317–354.
3. Acuna-Soto R, Braun-Roth G. Bleeding ulcer in common bile duct due to Fasciola hepatica. Am J Gastroenterol 1987;82:560–562.
4. Rana SS, Bhasin DK, Nanda M, et al. Parasitic infestations of the biliary tract. Curr Gastroenterol Rep 2007;9:156–164.
5. Belgraier AH. Common bile duct obstruction due to Fasciola hepatica. N Y State J Med 1976;76:936–937.
6. Ozer B, Serin E, Gümürdülü Y, et al. Endoscopic extraction of living Fasciola hepatica: case report and literature review. Turk J Gastroenterol 2003;14:74–77.
7. Hogan, WJ, Geenen JE. Biliary dyskinesia. Endoscopy 1988;20(suppl 1):179–183.
8. Veerappan A, Siegel JH, Podany J, et al. Fasciola hepatica pancreatits: endoscopic extraction of live parasites. Gastrointest Endosc 1991;37:473–475.
9. Dias LM, Silva R, Viana HL, et al. Biliary fascioliasis: diagnosis, treatment and follow-up by ERCP. Gastrointest Endosc 1996;43:616–620.
10. Gulsen MT, Savas MC, Koruk M, et al. Fascioliasis: a report of five cases presenting with common bile duct obstruction. Neth J Med 2006;64:17–19.
11. Boray JC, Crowfoot PD, Strong MB, et al. Treatment of immature and mature Fasciola hepatica infections in sheep with triclabenazole. Vet Rec 1983;113:315–317.
12. Overend DJ, Bowen FL. Resistance of Fasciola hepatica to triclabendazole. Aust Vet J 1995;72:275–276.
13. Favennec L, Jave Ortiz J, Gargala G, et al. Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru. Aliment Pharmacol Ther 2003;17:265–270.
14. White CA Jr. Nitazoxanide: a new broad spectrum antiparasitic agent. Expert Rev Anti Infect Ther 2004;2:43–49.